Market Closed -
Nasdaq Helsinki
11:29:30 2024-05-08 am EDT
|
Pre-market
02:02:07 am
|
4.362
EUR
|
-5.38%
|
|
4.388
|
+0.60%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,042
|
2,189
|
-
|
-
|
Enterprise Value (EV)
1 |
2,042
|
2,189
|
2,189
|
2,189
|
P/E ratio
|
12.7
x
|
12.1
x
|
13.9
x
|
13.5
x
|
Yield
|
8.11%
|
7.68%
|
8.57%
|
7.79%
|
Capitalization / Revenue
|
6.04
x
|
15.6
x
|
14.8
x
|
-
|
EV / Revenue
|
6.04
x
|
15.6
x
|
14.8
x
|
-
|
EV / EBITDA
|
11,154,084
x
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
1.28
x
|
1.36
x
|
1.33
x
|
1.45
x
|
Nbr of stocks (in thousands)
|
501,797
|
501,797
|
-
|
-
|
Reference price
2 |
4.070
|
4.362
|
4.362
|
4.362
|
Announcement Date
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
338.1
|
140.3
|
147.6
|
-
|
EBITDA
|
183.1
|
-
|
-
|
-
|
EBIT
1 |
178.3
|
210.3
|
198.6
|
179.8
|
Operating Margin
|
52.74%
|
149.93%
|
134.57%
|
-
|
Earnings before Tax (EBT)
1 |
210.4
|
225.5
|
194.4
|
204
|
Net income
1 |
160.7
|
180
|
155.2
|
163.4
|
Net margin
|
47.53%
|
128.3%
|
105.13%
|
-
|
EPS
2 |
0.3200
|
0.3600
|
0.3133
|
0.3231
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3300
|
0.3350
|
0.3740
|
0.3400
|
Announcement Date
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
167.6
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
51.3
|
-
|
48.43
|
47.83
|
47.38
|
Operating Margin
|
-
|
-
|
-
|
-
|
30.61%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
83.9
|
46.3
|
130.2
|
46.9
|
-
|
-
|
-
|
Net income
|
23.6
|
63.3
|
68.2
|
29.2
|
97.4
|
37.8
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
58.11%
|
-
|
-
|
-
|
-
|
EPS
|
-
|
0.3000
|
-
|
0.0600
|
0.0200
|
0.0800
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/10/23
|
8/16/23
|
11/8/23
|
2/13/24
|
2/13/24
|
5/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.8%
|
11.1%
|
10.6%
|
10.3%
|
ROA (Net income/ Total Assets)
|
1.03%
|
1.1%
|
0.93%
|
0.8%
|
Assets
1 |
15,596
|
16,320
|
16,720
|
20,323
|
Book Value Per Share
2 |
3.190
|
3.220
|
3.290
|
3.010
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/24
|
-
|
-
|
-
|
Last Close Price
4.362
EUR Average target price
3.98
EUR Spread / Average Target -8.76% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.17% | 2.36B | | +13.43% | 79.29B | | +9.69% | 51.58B | | +3.49% | 48.51B | | +20.18% | 46.18B | | +13.73% | 42.35B | | +26.04% | 40.27B | | +6.85% | 31.18B | | -1.87% | 29.34B | | +13.01% | 23.4B |
Other Life & Health Insurance
|